Table 1 Differential expression of proteins in SCC/HPV-16 against control (without SIL and HPV infection)
Protein | Expression index (n+/−) | Accession number | Chromosomal localization | Gene | Peptide coverage (%) | Score |
|---|---|---|---|---|---|---|
Mimecan | 38.85 | MIME_HUMAN | 9q22 | OGN | 46 | 956 |
Mimecan | 31.23 | MIME_HUMAN | 9q22 | OGN | 54 | 820 |
Actin, aortic smooth muscle | 19.14 | ACTA_HUMAN | 10q23.31 | ACTA2 | 59 | 311 |
Mimecan | 17.77 | MIME_HUMAN | 9q22 | OGN | 54 | 447 |
Lumican | 16.52 | LUM_HUMAN | 12q21.33 | LUM | 40 | 556 |
Peroxiredoxin-1 | −8.37 | PRDX1_HUMAN | 1p34.1 | PRDX1 | 79 | 968 |
14-3-3 protein sigma | −14.97 | 1433S_HUMAN | 1p36.11 | SFN | 67 | 977 |
Alpha-enolase | −17.38 | ENOA_HUMAN | 1p36.2 | ENO1 | 71 | 976 |
Keratin, type II cytoskeletal 5 | −39.7 | K2C5_HUMAN | 12q13.13 | KRT5 | 52 | 885 |
Keratin, type II cytoskeletal 5 | −65.34 | K2C5_HUMAN | 12q13.13 | KRT5 | 52 | 1 090 |